[SCHEDULE 13G/A] Alignment Healthcare, Inc. SEC Filing
FMR LLC (parent of Fidelity Investments) and its chair Abigail P. Johnson filed Amendment No. 4 to Schedule 13G reporting a passive stake in Alignment Healthcare (ALHC).
- Shares owned: 11,279,800.70 common shares.
- Percent of class: 5.7 % as of the event date 30 Jun 2025.
- Voting power: FMR holds sole voting power over 11,277,456.23 shares; Johnson reports no direct voting power.
- Dispositive power: FMR and Johnson each have sole dispositive power over the full 11.28 m shares; no shared powers are disclosed.
The filing is made under Rule 13d-1(b)/(c), confirming the stake is held in the ordinary course of business with no intent to influence control. The signature is dated 5 Aug 2025 and executed by Richard Bourgelas under existing power of attorney.
Crossing the 5 % threshold positions Fidelity as a significant institutional shareholder, potentially broadening ALHC’s investor base and adding passive support to the stock’s float; however, the filing provides no insight into future trading intentions.
- Fidelity complex holds 5.7 % of ALHC, adding a well-known institutional investor to the register and potentially improving share liquidity.
- None.
Insights
TL;DR: Fidelity now owns 5.7 % of ALHC, signalling institutional interest but with passive intent.
FMR’s 11.28 m-share position places the Fidelity complex among ALHC’s top holders, lending liquidity and potential confidence for other investors. Because the stake is reported on Schedule 13G, not 13D, Fidelity states it is acting passively, implying limited governance influence. The disclosure is moderately positive; large-cap fund flows can reduce share-price volatility, yet the firm is free to trim the position without notice below the 5 % threshold.
TL;DR: Passive filing means no control ambitions; governance impact minimal.
The amendment clarifies sole dispositive authority resides with FMR, while Johnson, as control person, mirrors the economic interest. With no shared voting arrangements and explicit certification of passive intent, the filing does not alter ALHC’s governance landscape. Investors should view this as a routine regulatory update rather than a catalyst for strategic change.